Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABMD - Replacement Heart System -- Ignore unavailable to you. Want to Upgrade?

To: High-Tech East who wrote (6)	11/12/1999 10:27:00 AM
From: BostonView	Respond to of 147

Somebody has a jones for ABMD today. A fund building a position, perhaps? With such a low float there's no telling where this buying could take us. BV

To: High-Tech East who wrote (6)	11/12/1999 12:35:00 PM
From: BostonView	Read Replies (1) \| Respond to of 147

ABMD action based on takeover speculation. NEW YORK, Nov 12 (Reuters) - Shares of ABIOMED Inc. (NasdaqNM:ABMD - news) jumped 21 percent early on Friday, with analysts saying the developer of an experimental replacement heart was a potential takeover target. Shares rose about 5-1/2 to 31-1/4 in Nasdaq trade. Analysts said ABIOMED is one of four companies developing and manufacturing heart replacement and circulatory devices, known as ventricular assist companies. ''Someone may look at ABIOMED as an inroad into the ventricular assist marketplace,'' said Justin Viacek, an analyst with the investment bank Cruttenden Roth Inc. The company hopes to begin testing its replacement heart on humans by the end of next year. The company declined immediate comment.